1. Canada Stocks

  2. •

    Financial Services

  3. •

    Financial - Conglomerates
Grey Wolf Health Corp.

Grey Wolf Health Corp.

WOLF.V
Grey Wolf Health Corp.CA flagToronto Stock Exchange Ventures
1.73
CAD
+0.12
- -
59.93MMarket Cap
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.42
1.35
0.82
0.76
1.05
1.1
Basic EPS, GAAP
-0.03
0.15
0.02
0.02
0.05
0.04
Free Cash Flow per Basic Share
0.07
-0.05
0.07
0.03
0.1
0.13
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
0.13
0.78
0.81
0.84
0.89
0.92
Tangible Book Value per Share
-0.69
- -
0.05
-0.4
-0.3
-0.24
Basic Weighted Avg Shares
31
17
31
35
34
34
Sales/Revenue/Turnover
13
23
25
27
36
38
Operating Margin (%)
0.54
-1.57
6.12
7.1
11.34
10.53
Depreciation Expense
1
2
1
2
3
3
Net Income, GAAP
-1
3
1
1
2
2
Effective Tax Rate (%)
- -
- -
44.5
49.37
30.31
34.02
Profit Margin (%)
-7.4
11.24
2.4
2.63
4.63
4.05
Working Capital
-11
8
9
8
10
11
LT Debt
11
10
9
25
23
22
Total Equity
4
24
25
29
31
32
Return on Invested Capital (%)
- -
- -
2.45
2.11
5.02
4.64
Return on Capital (%)
- -
- -
2.68
2.28
5.14
4.73
Return on Common Equity (%)
- -
17.96
2.47
2.61
5.58
4.97

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
2
2
2
LT Borrowings
23
22
22
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
34
34
35
Market Capitalization
45
46
61

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
16
17
18
Cash, Cash Equivalents & STI
8
9
9
Accounts Receivable, Net
2
2
3
Inventories
6
5
6
Total Current Liabilities
6
6
6
Payables & Accruals
4
4
4
ST Debt
2
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
6.01%
Free Cash Flow
- -
- -
173.18%
Net Income, GAAP
- -
- -
135.11%
Sales/Revenue/Turnover
- -
- -
33.3%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
6
7
7
7
27
2025
8
10
9
9
36
2026
9
11
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.02
0.02
-0.02
0.02
2025
- -
0.02
0.02
- -
0.05
2026
- -
0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Angela Cechetto
Sector
Financial Services
Industry
Financial - Conglomerates
Address
Bay Adelaide – West Tower Toronto ON Canada M5H 2R2
IPO Date
Nov 23, 2022
Website
greywolfah.com
Similar Companies
Largo Physical Vanadium Corp. (VAND.V)
Apogee Minerals Ltd (APMI.V)
Edelweiss Financial Services Limited (EDELWEISS.BO)
Reeflex Solutions Inc. (RFX.V)
Vendome Acquisition Corporation I (VNME)
Financial Gravity Companies, Inc. (FGCO)
Business
Grey Wolf Health Corp. is a Canadian diversified health company that commercializes prescription and non-prescription products for animal and human health markets in Canada. The Company operates through Animal Health and Pharmacy business units, focusing on products and tailored formulations that address unmet needs of veterinarians, companion-animal owners, physicians and patients. Its Animal Health portfolio includes gastrointestinal-health products for acute gastrointestinal upset; wound-care products, including the Activon medical-grade Manuka honey range; veterinary prescription injectables, including Ataject and Sedaject; behavioral-health nutraceuticals, including Composure Pro; end-of-life products; and other established and newly introduced veterinary products. Its Pharmacy operations provide compounded prescription products and specialized formulations, including solutions for equine and other animal-health applications, through its Trutina Pharmacy business. Grey Wolf Health employs an in-licensing, acquisition and compounding strategy to commercialize differentiated products in Canada and serves veterinary clinics, animal-health professionals, physicians, patients and animal owners. Founded in 2015 by veterinarian Dr. Ian Sandler, the Company is headquartered in Toronto, Ontario, Canada; it acquired Veterinary Healthcare Solutions in 2018 to establish a nationwide commercial footprint and acquired Trutina Pharmacy in 2021. In June 2026, the Company changed its name from Grey Wolf Animal Health Corp. to Grey Wolf Health Corp., while retaining the TSX Venture Exchange ticker symbol WOLF, to reflect its expansion from a veterinary-focused company into a broader human and animal health platform. Recent operational initiatives include investment in a new enterprise-resource-planning system, a new compounding facility in Ancaster, Ontario, and the appointment of a Vice President of Sales & Marketing to oversee commercial activity across the Pharmacy and Animal Health units.